CD Bioparticles specializes in the production of advanced drug delivery systems utilizing various nanoparticle technologies. Their offerings include polymeric nanoparticles made from materials such as chitosan, PMMA, PHA, and PLGA, which are designed for effective drug loading and release. Additionally, the company provides a comprehensive range of liposome products, which are crucial for enhancing the delivery of pharmaceuticals, cosmetics, and nucleic acids. CD Bioparticles also focuses on metal-organic frameworks (MOFs) and hydrogen-bonded organic frameworks (HOFs), which are innovative materials with unique porous structures that can be tailored for specific applications in drug delivery and biocompatibility.

Furthermore, CD Bioparticles is committed to developing functional biomedical coatings and bioactive matrices for applications in tissue engineering and cell culture. Their product line includes advanced scaffolds for tissue engineering, transfection reagents for gene delivery, and a variety of cleavable linkers and chelating agents for drug development. The company also emphasizes the importance of formulation design and characterization, offering services that support the development of targeted drug delivery systems and enhance the efficacy of therapeutic agents across various medical fields.

United States

CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems.

CD Bioparticles

Company Details